PARP1 and metabolic dysfunction-associated steatotic liver disease: PARP1 is activated in the liver of HFD-fed mice and suppressed PPARα signaling.365 A PARP inhibitor olaparib reversed NAFLD by NAD+ elevation, increasing mitochondrial biogenesis and β-oxidation in liver under HFHS diet.366